Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

: Medicinal Product - Herceptin (trastazumab) 150 mg for Intravenous Use - JSON Representation

Raw json | Download


{
  "resourceType" : "MedicinalProductDefinition",
  "id" : "medprodherceptin150",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name=\"medprodherceptin150\"> </a><a name=\"hcmedprodherceptin150\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicinalProductDefinition &quot;medprodherceptin150&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://iyaku.info/medicine</code>/4291447D2024</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html\">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html\">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Herceptin (trastazumab) 150 mg</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Herceptin</p><p><b>type</b>: Invented name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: trastazumab</p><p><b>type</b>: Scientific name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 150 mg</p><p><b>type</b>: Strength part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Intravenous infusion</p><p><b>type</b>: Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#100000075213)</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japanese (Region=Japan) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#ja-JP)</span></td></tr></table></blockquote></div>"
  },
  "identifier" : [
    {
      "system" : "http://iyaku.info/medicine",
      "value" : "4291447D2024"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/medicinal-product-type",
        "code" : "MedicinalProduct",
        "display" : "Medicinal Product"
      }
    ]
  },
  "domain" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/medicinal-product-domain",
        "code" : "Human",
        "display" : "Human use"
      }
    ]
  },
  "status" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/publication-status",
        "code" : "active",
        "display" : "active"
      }
    ]
  },
  "legalStatusOfSupply" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/rmswi",
        "code" : "100000072084",
        "display" : "Medicinal product subject to medical prescription"
      }
    ]
  },
  "name" : [
    {
      "productName" : "Herceptin (trastazumab) 150 mg",
      "type" : {
        "coding" : [
          {
            "system" : "https://spor.ema.europa.eu/lists/220000000000",
            "code" : "220000000001"
          }
        ],
        "text" : "Full name"
      },
      "part" : [
        {
          "part" : "Herceptin",
          "type" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/lists/220000000000",
                "code" : "220000000002"
              }
            ],
            "text" : "Invented name part"
          }
        },
        {
          "part" : "trastazumab",
          "type" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/lists/220000000000",
                "code" : "220000000003"
              }
            ],
            "text" : "Scientific name part"
          }
        },
        {
          "part" : "150 mg",
          "type" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/lists/220000000000",
                "code" : "220000000004"
              }
            ],
            "text" : "Strength part"
          }
        },
        {
          "part" : "Intravenous infusion",
          "type" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/lists/220000000000",
                "code" : "100000075213"
              }
            ],
            "text" : "Pharmaceutical dose form part"
          }
        }
      ],
      "usage" : [
        {
          "country" : {
            "coding" : [
              {
                "system" : "urn:iso:std:iso:3166",
                "code" : "JP"
              }
            ]
          },
          "jurisdiction" : {
            "coding" : [
              {
                "system" : "urn:iso:std:iso:3166",
                "code" : "JP"
              }
            ]
          },
          "language" : {
            "coding" : [
              {
                "system" : "urn:ietf:bcp:47",
                "code" : "ja-JP"
              }
            ]
          }
        }
      ]
    }
  ]
}